4-Cyclobutyl-6-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine

Poly(oxy-1,2-ethanediyl), I+/--hydro-I-hydroxy-, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol and N2,N6-bis[N2,N6-bis[(1,1-dimethylethoxy)carbonyl]-L-lysyl]-N-(2-hydroxyethyl)-L-lysinamide (4:1:4)

Hexatriacontane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,26,26,27,27,28,28,29,29,30,30,31,31,32,32,33,33,34,34,35,35,36,36,36-hexatetracontafluoro-13,24-diiodo-

I(2)-D-Glucopyranosiduronic acid, (11I(2),16I+/-)-16,17-[butylidenebis(oxy)]-9-fluoro-11-hydroxy-3,20-dioxopregna-1,4-dien-21-yl, methyl ester, 2,3,4-triacetate

4-(Bromomethyl)-2,2,4-trimethylheptane

2-(Bromomethyl)-8-methyl-1,4-dioxa-8-azaspiro[4.6]undecane

1-(4-Iodobenzenesulfonyl)aziridine

2-amino-3-(1,3-dimethyl-1H-pyrazol-5-yl)-3-hydroxypropanoic acid

7-bromo-1-(2-methylpropyl)-1H-1,3-benzodiazole

O-[(4-bromo-5-methylthiophen-2-yl)methyl]hydroxylamine

Methyl 2-((5-fluoropyrimidin-2-yl)amino)nicotinate